Keytruda (pembrolizumab) - Merck (MSD)
ONCR-177 - Oncorus
https://cslide.ctimeetingtech.com/esmo2024/attendee/confcal_2/presentation
 
C. Fava Gaspar1; J.C. Park2; G.S. Falchook3; R. Wesolowski4; H. Soliman5; P.A. Ott6; M.A. Bilen7; M. Mckean8; V. Villaflor9; L.Q.M. Chow10; A. Yanez11; C. Dupont11; J. Shepherd11; T. Cheema11; J.M. Goldberg11; I. Puzanov12; A. Spreafico1
 
Jul 25, 2024
 
Next